Comparison of implant quality between loose and intra-operatively linked iodine-125 seeds in prostate cancer brachytherapy

Journal of Radiation Research

Volumn 53, Issue 3, 2012, Pages 439-446

  Jarusevicius, Laimonas ^a   Inciura, Arturas ^a   Juozaityte, Elona ^a   Vaiciunas, Kestutis ^a   Vaitkus, Antanas ^a   Sniureviciute, Migle ^a  

^a LITHUANIAN UNIVERSITY OF HEALTH SCIENCES   (Lithuania)

Author keywords

Learning curve; Linked seeds; Loose seeds; Prostate brachytherapy; Prostate cancer

Indexed keywords

IODINE; ONCOLOGY; PATIENT MONITORING; QUALITY CONTROL; RADIOTHERAPY; UROLOGY;

HOMOGENEITY INDEX; IMPLANT QUALITY; IODINE-125; LEARNING CURVES; LINKED SEED; LOOSE SEED; PROSTATE BRACHYTHERAPY; PROSTATE CANCERS; PROSTATE VOLUME; SEED IMPLANTATION;

DISEASES;

EID: 84863455681     PISSN: 04493060     EISSN: 13499157     Source Type: Journal    
DOI: 10.1269/jrr.11064     Document Type: Review

References (29)

1. Marshall DT (2007) Options and recent advances in permanent brachytherapy for prostate cancer. Can J Urol 14(1): 28-31.
2. Stock RG, et al (1995) A modified technique allowing interactive ultrasound-guided three-dimensional transperineal prostate implantation. Int J Radiat Oncol Biol Phys 32: 219-225.
3. Potters L, et al (2003) Toward a dynamic real-time intraoperative permanent prostate brachytherapy methodology. Brachytherapy 2: 172-180.
4. Nag S, et al (2000) The American Brachytherapy Society recommendations for permanent prostate brachytherapy postimplant dosimetric analysis. Int J Radiat Oncol Biol Phys 46: 221-230.
5. Saw CB, et al (1991) Quantitative assessment of interstitial implants. Int J Radiat Oncol Biol Phys 20:135-139.
6. Stock RG, et al (1998) A dose-response study for 1-125 prostate implants. Int J Radiat Oncol Biol Phys 41: 101-108.
7. Zelefsky MJ, et al (1997) Long term results of retfopubic permanent 125 I implantation of the prostate for clinically localized prostate cancer. J Urol 158: 23-30.
8. Stock RG, et al (1996) Prostate specific antigen findings and biopsy results following interactive ultrasound guided transperineal brachytherapy for early stage prostate carcinoma. Cancer 77: 2386-2392.
9. Vijverberg PLM, et al (1993) Analysis of biopsy findings and implant quality following ultrasonically guided 125 I implantation for localised prostatic carcinoma. Br J Urol 33: 470-477.
10. Potters L, et al (2005) 12 years outcomes following permanent prostate brachytherapy in patients with clinically localized prostate cancer. J Urol 173: 1562-1566.
11. Zelefsky MJ, et al (2007) Multi-institutional analysis of longterm outcome for stages T1-T2 prostate cancer treated with permanent seed implantation. Int J Radiat Oncol Biol Phys 67: 327-333.
12. Potters L, et al (2001) A Comperhensive review of CT-based dosimetry parameters and biochemical control in patients treated with permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 50: 65-614.
13. Joseph J, et al (2004) Prostate specific antigen relapse-free survival in patients with localized prostate cancer treated by brachytherapy. BJU Int 94: 1235-1238.
14. Moerland MA, et al (2009) Decline dose coverage between intraoperative planning and post implant dosimetry for 1-125 permanent prostate brachytherapy: comparison between loose and stranded seed implants. Radiother Oncol 91: 202-206.
15. McLaughlin P, et al (2006) Comparison of day 0 and day 14 dosimetry for permanent prostate implants using stranded seeds. Int J Radiat Oncol Biol Phys 64: 144-150.
16. Lee WR, et al (2002) Radioactive sources embedded in suture are associated with improved post-implant dosimetry in men treated with prostate brachytherapy. Radiother Oncol 65: 123-127.
17. Fagundes HM, et al (2004) Transperineal TRUS-guided prostate brachytherapy using loose seeds versus RAPIDStrand: a dosimetric analysis. Brachytherapy 3: 136-140.
18. Fuller DB, et al (2004) Prostate brachytherapy seed migration and dosimetry: analysis of stranded sources and other potential predictive factors. Brachytherapy 3: 10-19.
19. Heysek RV, et al (2006) A dosimetric analysis of unstranded seeds versus customized stranded seeds in transperineal interstitial permanent prostate seed brachytherapy. Brachytherapy 5: 244-250.
20. Reed DR, et al (2007) A prospective randomized comparison of stranded vs. loose 1251 seeds for prostate brachytherapy. Brachytherapy 6: 129-134.
21. Saibishkumar EP, et al (2009) Sequential comparison of seed loss and prostate dosimetry of stranded seeds with loose seeds in 1251 permanent implant for low-risk prostate cancer. Int J Radiat Oncol Biol Phys 73: 61-68.
22. Hinnen KA, et al (2010) Loose seeds versus stranded seeds in 1-125 prostate brachytherapy: differences in clinical outcome. Radiother Oncol 96: 30-3.
23. Zauls AJ, et al (2010) Comparison of inuaoperatively built custom linked seeds versus seed gun applicator technique using real-time intraoperative planning for permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys. [Epub ahead of print].
24. Bladou F, et al (2004) Permanent iodine 125 implant brachytherapy in localized prostate cancer: results of the first 4 years of experience. Prog Urol 14: 345-352.
25. Hoinkis C, et al (2004) Evaluation of dose-volume histograms after prostate seed implantation. 4-year experience. Strahlenther Onkol 180: 550-556.
26. Lee WR, et al (2000) Post-implant analysis of transperineal interstitial permanent prostate brachytherapy: evidence for a learning curve in the first year at a single institution. Int J Radiat Oncol Biol Phys 46: 83-88.
27. Liu HW, et al (2010) The dosimetric quality of brachytherapy implants in patients with small prostate volume depends on the experience of the brachytherapy team. Brachytherapy 9: 202-207.
28. Butler WM, et al (2011) Evaluation of radiobiologic biochemical control in a large permanent prostate brachytherapy population from a single institution using AAPM TG-137 parameters. Brachytherapy 10: 16-28.
29. Acher P, et al (2006) Permanent prostate brachytherapy: Dosimetric results and analysis of a learning curve with a dynamic dose-feedback technique. Int J Radiat Oncol Biol Phys 65: 694-698.